JFG
PFE icon

Jefferies Financial Group’s Pfizer PFE Stock Holding History

Jefferies Financial Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100
Closed -$2.49K – 2101
2025
Q4 		$2.49K Hold
100
– – ﹤0.01% 1821
2025
Q3 		$2.55K Hold
100
– – ﹤0.01% 1423
2025
Q2 		$2.42K Sell
100
-14,000
-99% -$326K ﹤0.01% 1243
2025
Q1 		$357K Sell
14,100
-82,000
-85% -$2.15M ﹤0.01% 1160
2024
Q4 		$2.55M Hold
96,100
– – 0.02% 586
2024
Q3 		$2.78M Sell
96,100
-300,000
-76% -$8.75M 0.02% 483
2024
Q2 		$11.1M Buy
396,100
+235,900
+147% +$6.49M 0.12% 141
2024
Q1 		$4.45M Sell
160,200
-75,400
-32% -$2.09M 0.04% 332
2023
Q4 		$6.78M Buy
+235,600
New +$7.12M 0.04% 320
2023
Q1 		– Sell
-110,000
Closed -$5.64M – 1904
2022
Q4 		$5.64M Buy
+110,000
New +$5.27M 0.04% 373

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Jefferies Financial Group's PFE Position: Q2 2026 in Review

Jefferies Financial Group reduced its Pfizer (PFE) stake by 30% in Q2 2026, selling an estimated $7.36M and leaving 642,123 shares worth $15.5M. The position accounts for 0.1% of the portfolio, ranked #181.

Jefferies Financial Group first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $35.3M in Q4 2024. 2,839 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Jefferies Financial Group held 642,123 shares of Pfizer worth $15.5M as of Q2 2026.
  • Jefferies Financial Group sold 281,197 Pfizer shares in Q2 2026, an estimated $7.36M.
  • Pfizer made up 0.1% of Jefferies Financial Group's portfolio in Q2 2026, its #181 holding.
  • Jefferies Financial Group first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
  • Jefferies Financial Group's Pfizer position peaked at $35.3M in Q4 2024.
  • 2,839 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.